
Altrip6.25 mg
NIPRO JMI Pharma Ltd.
Almotriptan is a selective serotonin (5-HT1B/1D) receptor agonist (triptan) indicated for the following: FDA-Approved / Established Use Acute treatment of migraine with or without aura in adults.
Almotriptan is a selective serotonin (5-HT1B/1D) receptor agonist (triptan) indicated for the following:
Dosing of Almotriptan should be individualized based on age, hepatic/renal function, and concomitant medications.
| Population/Condition | Recommended Dosing of Almotriptan |
|---|---|
| Adults | 6.25 mg or 12.5 mg as a single oral dose at onset of migraine; may repeat once after 2 hours if headache returns (maximum 25 mg in 24 hours). 12.5 mg has shown greater consistency of effect than 6.25 mg. |
| Adolescents (12–17 years) | 6.25 mg or 12.5 mg single dose; no additional benefit has been shown with the higher dose in this age group. Maximum 2 doses in 24 hours. |
| Hepatic impairment | Start with 6.25 mg; maximum 12.5 mg in 24 hours. |
| Severe renal impairment | Start with 6.25 mg; maximum 12.5 mg in 24 hours. |
| With potent CYP3A4 inhibitors (e.g., ketoconazole) | Start with 6.25 mg; maximum 12.5 mg in 24 hours; avoid combination in patients with renal or hepatic impairment. |
If a patient does not respond to the first dose of Almotriptan for a given attack, the effectiveness of a second dose for the same attack has not been established; consider an alternative treatment for that episode.
The most commonly reported adverse effects of Almotriptan are generally mild and transient.
Patients experiencing chest, throat, neck, or jaw tightness/pain after taking Almotriptan should seek prompt medical evaluation.
Almotriptan is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.